Haemophilia logo Wiley-Blackwell logo

Publisher: Wiley-Blackwell

Related content
Volume 10, Supplement 4, October 2004

< previous issue | all issues | next issue >

WFH: back to the future
pp. 1-8(8)
Author: O'Mahony, B.

Comprehensive care for haemophilia around the world
pp. 9-13(5)
Authors: Evatt, B. L.; Black, C.; Batorova, A.; Street, A.; Srivastava, A.

Haemophilia in the developing world: successes, frustrations and opportunities
pp. 14-19(6)
Authors: Tezanos Pinto, M.; Ortiz, Z.

Evidence-based treatment of haemophilia
pp. 20-24(5)
Authors: Bolton-Maggs, P. H. B.; Stobart, K.; Smyth, R. L.

Disease-specific quality-of-life measurement tools for haemophilia patients
pp. 30-34(5)
Authors: Remor, E.; Young, N. L.; Von Mackensen, S.; Lopatina, E. G.

Minimizing factor requirements for surgery without increased risk
pp. 35-40(6)
Authors: Schulman, S.; Loogna, J.; Wallensten, R.

The impact of information technology on haemophilia care
pp. 41-46(6)
Authors: Baker, R. I.; Laurenson, L.; Winter, M.; Pritchard, A. M.

Emerging and receding risks of therapeutic regimens for haemophilia
pp. 47-54(8)
Authors: Farrugia, A.; Manno, C. S.; Evatt, B. L.

New high-technology products for the treatment of haemophilia
pp. 55-63(9)
Authors: Pipe, S. W.; Saint-Remy, J-M.; Walsh, C. E.

Haemophilic factors produced by transgenic livestock: abundance that can enable alternative therapies worldwide
pp. 70-76(7)
Authors: Van Cott, K. E.; Monahan, P. E.; Nichols, T. C.; Velander, W. H.

Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions
pp. 88-93(6)
Authors: Manco-Johnson, M. J.; Pettersson, H.; Petrini, P.; Babyn, P. S.; Bergstrom, B-M.; Bradley, C.-S.; Doria, A. S.; Feldman, B. M.; Funk, S.; Hilliard, P.; Kilcoyne, R.; Lundin, B.; Nuss, R.; Rivard, G.; Schoenmakers, M. A. G. C.; Van den berg, M.; Wiedel, J.; Zourikian, N.; Blanchette, V. S.

Optimizing factor prophylaxis for the haemophilia population: where do we stand?
pp. 97-104(8)
Authors: Blanchette, V. S.; Manco-Johnson, M.; Santagostino, E.; Ljung, R.

Essential issues of laboratory investigation for patients with haemophilia and bleeding disorders
pp. 105-108(4)
Authors: Chuansumrit, A.; McCraw, A.; Preston, E. F.

What is a cure and how do we get there?
pp. 115-118(4)
Authors: Skinner, M. W.; Lillicrap, D. P.; McMillan, J.; Castro Ozelo, M.; Pierce, G. F.

Preclinical and clinical gene therapy for haemophilia
pp. 119-125(7)
Authors: Chuah, M. K. L.; Collen, D.; Vandendriessche, T.

Molecular basis of haemophilia A
pp. 133-139(7)
Authors: Oldenburg, J.; Ananyeva, N. M.; Saenko, E. L.

Inhibitors in haemophilia: clinical aspects
pp. 140-145(6)
Authors: Dimichele, D.; Rivard, G.; Hay, C.; Antunes, S.

Inhibitors in haemophilia: pathophysiology
pp. 146-151(6)
Authors: Saint-Remy, J-M. R.; Lacroix-Desmazes, S.; Oldenburg, J.

The target joint
pp. 152-156(5)
Authors: Mulder, K.; LlinĂ¡s, A.

Functional recovery after bleeding episodes in haemophilia
pp. 157-160(4)
Authors: De Kleijn, P.; Gilbert, M.; Roosendaal, G.; Poonnose, P. M.; Narayan, P. M.; Tahir, N.

Risks and benefits of sports and fitness activities for people with haemophilia
pp. 161-163(3)
Authors: Mulder, K.; Cassis, F.; Seuser, D. R. A.; Narayan, P.; Dalzell, R.; Poulsen, W.

von Willebrand disease: laboratory aspects of diagnosis and treatment
pp. 164-168(5)
Authors: Favaloro, E. J.; Lillicrap, D.; Lazzari, M. A.; Cattaneo, M.; Mazurier, C.; Woods, A.; Meschengieser, S.; Blanco, A.; Kempfer, A. C.; Hubbard, A.; Chang, A.

Clinical diagnosis of von Willebrand disease
pp. 169-176(8)
Author: Federici, A. B.

Clinical picture and management of congenital factor VII deficiency
pp. 180-183(4)
Authors: Mariani, G.; Dolce, A.; Marchetti, G.; Bernardi, F.

New observations on factor XI deficiency
pp. 184-187(4)
Authors: Salomon, O.; Seligsohn, U.

Acquired bleeding disorders: the impact of health problems in the developing world
pp. 188-195(8)
Authors: Isarangkura, P.; Mahasandana, C.; Chuansumrit, A.; Angchaisuksiri, P.

The role of haemophilia treatment centres in providing services to women with bleeding disorders
pp. 196-204(9)
Authors: Winikoff, R.; Amesse, C.; James, A.; Lee, C.; Pollard, D.

Hepatitis C in haemophilia: lights and shadows
pp. 211-215(5)
Authors: Rumi, M. G.; De Filippi, F.; Santagostino, E.; Colombo, M.

Dose and outcome of care in haemophilia – how do we define cost-effectiveness?
pp. 216-220(5)
Authors: Fischer, K.; Van Den Berg, H. M.; Thomas, R.; Kumar, S.; Poonnoose, P.; Viswabandya, A.; Mathews, V.; Kavitha, M. L.; Bhattacharji, S.; Srivastava, A.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page